First Header Logo Second Header Logo

Connection

Kenneth Zamkoff to Treatment Outcome

This is a "connection" page, showing publications Kenneth Zamkoff has written about Treatment Outcome.
Connection Strength

0.041
  1. Gladstone DE, Golightly MG, Zamkoff KW. Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil. Rheumatol Int. 2005 Oct; 25(8):635-6.
    View in: PubMed
    Score: 0.032
  2. Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis. Arch Neurol. 2006 Oct; 63(10):1388-93.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.